News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CISBIO Announces FDA Approval of MESOMARK(R) Assay; Now Availabe to Physicians in the U.S. for Monitoring Patients with Mesothelioma


3/26/2007 1:54:23 PM

SACLAY, France--(BUSINESS WIRE)--CISBIO, a developer and marketer of diagnostic assays for the quantification of tumor markers, announced that the MESOMARK® Assay, the world’s first in vitro test for managing patients with mesothelioma, an aggressive and deadly form of cancer, has been approved by the United States Food and Drug Administration (FDA). The MESOMARK® test is developed and manufactured by Fujirebio Diagnostics, Inc. of Malvern, PA; CISBIO is the exclusive distributor of MESOMARK® in Europe, where it is currently undergoing evaluation for clinical use.

>>> Discuss This Story


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES